TTK Healthcare Limited (TTKHLTCARE) fundamentals
TTK Healthcare Limited is a listed company in Diversified, part of the Diversified sector, listed on the NSE as TTKHLTCARE (ISIN INE910C01018). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What TTK Healthcare Limited does
TTK Healthcare Limited is an India-based company providing consumer and healthcare products. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others. The Animal Welfare segment offers products for veterinary use, including the brands Ossomin, Orcal-P, Epidosin, and others. The Consumer Products segment markets and distributes Woodward's Gripe Water, the EVA range of cosmetics, the Good Home range of scrubbers, air fresheners, and various other products. The Medical Devices segment includes the manufacturing and marketing of artificial heart valves, orthopedic implants, and others. The Protective Devices segment focuses on manufacturing and marketing male contraceptives and related products. The Foods segment involves the manufacturing and marketing of food products. Extruded products, such as papads, are offered under the brand name Fryums. The Others segment includes the printing and publishing of maps and atlases.
Valuation and market data
| Last close | ₹1138.80 |
|---|---|
| Market capitalisation | ₹1,609 crore |
| Enterprise value | ₹1,595 crore |
| P/E (TTM) | 24.50 |
| Price to book | 1.44 |
| Price to sales (TTM) | 1.02 |
| Book value per share | ₹788.94 |
| Dividend yield | 87.81% |
| Sector | Diversified |
| Industry | Diversified |
| Listed since | Wed Dec 02 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹929 crore | ₹83 crore | ₹66 crore | 46.48 |
| Mar 2025 | ₹873 crore | ₹108 crore | ₹82 crore | 57.79 |
| Mar 2024 | ₹815 crore | ₹84 crore | ₹63 crore | 44.47 |
| Mar 2023 | ₹773 crore | ₹62 crore | ₹45 crore | 452.72 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 74.6% |
|---|---|
| Foreign institutions (FII) | 1.9% |
| Mutual funds | 0.0% |
| Other domestic institutions | 2.2% |
| Retail and others | 21.4% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.